[Therapeutic options to improve the microcirculation in sepsis and septic shock]. / Mikrozirkulation bei Sepsis und septischem Schock: Therapeutische Ansätze zur Verbesserung.
Hamostaseologie
; 27(1): 59-63, 2007 Feb.
Article
em De
| MEDLINE
| ID: mdl-17279278
ABSTRACT
The severe impairment of the microcirculation plays a substantial role in the pathogenesis of severe sepsis and septic shock, and leads to multiple organ failure and death. Therapeutic strategies to resuscitate the microcirculatory blood flow and to improve the functional capillar density are therefore essential to surmount the microcirculatory pathology and to avoid tissue hypoxia. Based on reasonable scientific evidence, early fluid resuscitation directed by defined haemodynamic and metabolic goals (EGDT) as well as the application of activated protein C (rhAPC) according to the guidelines could be recommended. Dobutamine is the first choice to improve cardiac output and to overcome myocardial depression in septic shock whereas phosphodiesterase-III-inhibitors and levosimendane are still experimental options. Furthermore selective inhibitors of iNOS, nitroglycerol, as well as vasopressin have to be investigated relating to their specific effects on the microcirculation and their influence on survival in seevere sepsis and septic shock.
Buscar no Google
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
/
4_TD
Base de dados:
MEDLINE
Assunto principal:
Choque Séptico
/
Sepse
/
Microcirculação
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
De
Revista:
Hamostaseologie
Ano de publicação:
2007
Tipo de documento:
Article